Nerve injury proximal or distal to the DRG induces similar spinal glial activation and selective cytokine expression but differential behavioral responses to pharmacologic treatment

Journal of Comparative Neurology

Volumn 439, Issue 2, 2001, Pages 127-139

  Winkelstein, Beth A ^a   Rutkowski, Maria D ^a   Sweitzer, Sarah M ^a   Pahl, Janice L ^a   Deleo, Joyce A ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

Behavioral sensitivity; IL 6; Neuropathy; Nociception; Radiculopathy; TNF

Indexed keywords

CYTOKINE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; LEFLUNOMIDE; TUMOR NECROSIS FACTOR RECEPTOR;

ALLODYNIA; ANIMAL EXPERIMENT; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; GLIA CELL; NEUROPATHY; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RADICULOPATHY; RAT; SPINAL GANGLION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD147; ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; AVIAN PROTEINS; BLOOD PROTEINS; CYTOKINES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GANGLIA, SPINAL; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-6; LUMBAR VERTEBRAE; MALE; MEMBRANE GLYCOPROTEINS; NEUROGLIA; PAIN; PERIPHERAL NERVOUS SYSTEM DISEASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER; SIALOGLYCOPROTEINS; SPINAL CORD; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035888084     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/cne.2000     Document Type: Article

References (39)

1. Intrathecal anti-IL-6 antibody and IgG attenuates peripheral nerve injury-induced mechanical allodynia in the rat: Possible immune modulation in neuropathic pain
2. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man
3. Low back pain: Epidemiology, anatomy and neurophysiology
4. Dissociation of microglial activation and neuropathic pain behaviors following peripheral nerve injury in the rat
5. The effect of site and type of nerve injury on spinal glial activation and neuropathic pain behavior
6. The role of cytokines in nociception and chronic pain
7. The role of neuroinflammation and neuroimmune activation in persistent pain
8. Characterization of a neuropathic pain model: Sciatic cryoneurolysis in the rat
9. Interleukin-6-mediated hyperalgesia/allodynia and increased spinal IL-6 expression in a rat mononeuropathy model
10. Cytokine and growth factor immunohistochemical spinal profiles in two animal models of mononeuropathy
11. Intrathecal catheterization alone induces neuroimmune activation in the rat
12. Spinal cyclooxygenase-2 (COX-2) inhibitor attenuates mechanical allodynia following nerve root injury in rats
13. The immunosuppressive metabolite of leflunomide, A771726, affects murine T cells through two biochemical mechanisms
14. Dorsal root section elicits signs of neuropathic pain rather than reversing them in rats with L5 spinal nerve injury
15. Staining of glial fibrillary acidic protein (GFAP) in lumbar spinal cord increases following a sciatic nerve constriction injury
16. Sympathetic-sensory coupling after L5 spinal nerve lesion in the rat and its relation to changes in dorsal root ganglion blood flow
17. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
18. Spinal glial activation and cytokine expression after lumbar root injury in the rat
19. Central administration of methotrexate reduces mechanical allodynia in an animal model of radiculopathy/sciatica
20. Interleukin-1beta induces substance P release from primary afferent neurons through the cyclooxygenase-2 system
21. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat
22. Sensory and sympathetic contributions to nerve injury-induced sensory abnormalities in the rat
23. Mechanical hyperalgesia after an L5 spinal nerve lesion in the rat is not dependent on input from injured nerve fibers
24. Immunosuppressive leflunomide metabolite (A77 1726) blocks blacks TNF-dependent nuclear factor-κB activation and gene expression
25. Leflunomide inhibits activation of inducible nitric oxide synthase in rat astrocytes
26. Pathogenesis of sciatic pain: Role of herniated nucleus pulposus and deformation of spinal nerve root and dorsal root ganglion
27. Lumbar nerve root injury induces CNS neuroimmune activation and neuroinflammation in the rat: Relationship to painful radiculopathy
28. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury
29. Signs of neuropathic pain depend on signals from injured nerve fibers in a rat model
30. Intrathecal NSAIDS attenuate inflammation-induced neuropeptide release from rat spinal cord slices
31. The effects of mechanical compression and hypoxia on nerve root and dorsal root ganglia
32. Nerve injury-induced tactile allodynia is mediated via ascending spinal dorsal column projections
33. Leflunomide, an immunosuppressive agent, reduces mechanical sensitivity in a rat mononeuropathy model
34. Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibit an anti-allodynic action in a rat model of neuropathic pain
35. The differential role of spinal MHC class II and cellular adhesion molecules in inflammatory versus neuropathic pain
36. Tonic descending facilitation from the rustral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance
37. Alterations in the central nervous system after deafferentation: Connectivity control
38. Autotomy following peripheral nerve lesions: Experimental anaesthesia dolorosa
39. The pain of being sick: Implications of immune-to-brain communication for understanding pain